Stock screener

BBIO

Conviction 61HealthcareScan · Thu, Jun 25, 2026
BBIO$69.65+0.42%
ResistanceSupportVol 14Insider sellCongress buyCongress sell
63 bars
Gilbert Cisneros
2
2
5
4
5
2
Vol MA14 2.78M
Mar 26Apr 14May 1May 19Jun 8Jun 25
BridgeBio Pharma, Inc.PHARMACEUTICAL PREPARATIONSwww.bridgebio.com ↗
Price69.65
Change+0.42%
Gap+0.88%
Rel volume2.10×
Avg volume3.09M
Avg $ vol207.27M
SMA 2067.30
SMA 5069.08
SMA 20067.88
Price vs 50+0.83%
Price vs 200+2.61%
MA stackbullish
50/200 cross—
Supertrenddown · 72.80
RSI (14)56
MACD hist0.42
MACD cross—
Stoch %K / %D78 / 79
ADX (14)9
+DI / −DI18 / 14
RSI divergence—
MACD divergence—
ATR %+3.69%
ADR %3.60%
52w high79.91
52w low42.78
From 52w high-12.84%
Above 52w low+62.81%
New 52w highNo
SqueezeOn · 23d
Bollinger width8.18%
%B0.93
Donchian pos86.46%
Donchian high70.77
Donchian low62.50
AVWAP (52w high)69.94
vs AVWAP high-0.42%
AVWAP (52w low)64.10
vs AVWAP low+8.66%
OBV trendFlat
Chaikin MF (20)-0.19
Today vs 20d2.10×
Avg vol (14d)2.78M
Avg vol (20d)3.09M
Avg $ vol (20d)207.27M
Market cap13.64B
RS 3m (vs SPY)-11.05%
RS 6m (vs SPY)-16.83%
RS line new highNo
Trend template5/8
Technical rank51.1
1 week+3.35%
1 month+2.83%
3 months-2.74%
6 months-9.65%
1 year+56.69%
YTD-10.97%
P/E—
P/B-5.99
P/S27.17
P/FCF-30.52
EPS-3.78
Div yield0.01%
ROE—
ROA—
Debt/Eq-0.00
Current1.52
EV/EBITDA-24.64
Gross margin—
Net margin—
Rev growth126.26%
EPS growth—
Price target106.22
Target upside52.51%
Analyst ratingBuy
Institutional109.50%
Ent. value12.77B
Revenue194.51M
Net income-69K
Gross profit—
Free cash flow-447.01M
IndustryPHARMACEUTICAL PREPARATIONS
ExchangeNasdaq
Shares out195.86M
Employees839
ListedThu, Jun 27, 2019
Free float149.14M
Float %76.2%
Short interest24.39M
Days to cover9.6d
Short volume24.0%
Squeeze score73 / 100
Next earningsTue, Aug 4, 2026 (40d)
EPS forecast−$0.64 · 7 est
Last EPS vs est−$0.84 vs −$0.70
Last surprise-20.0% miss
Setup gradeB
Conviction61 / 100
Pattern quality—
Tech rank51.1 / 100
Group rank50 / 100
Status lane—
Setup direction—
Pattern family
Resistance70.99
Support63.07
Days since event—
Candle confirm—
News sentiment—

Financials as of Sun, Jun 30, 2019 · quarterly.

Congress activity

Disclosed STOCK Act trades in BBIO · 4 recent

All disclosures →
MemberSideAmount
Gilbert Cisneros
Gilbert Cisneros
house · CA · traded 2026-05-11
Buy$1K–$15K
Gilbert Cisneros
Gilbert Cisneros
house · CA · traded 2026-03-19
Buy$1K–$15K
Gilbert Cisneros
Gilbert Cisneros
house · D · CA · traded 2025-09-22
Buy$1K–$15K
Gilbert Cisneros
Gilbert Cisneros
house · D · CA · traded 2025-08-08
Buy$1K–$15K

Insider activity

SEC Form 4 transactions in BBIO · 5 buys · 5 sells

InsiderSideShares
Cook Jennifer E.
Director · Stock Option (Right to Buy) · 2026-06-24
Exercise17.17K
Cook Jennifer E.
Director · Common Stock · 2026-06-24
Exercise20K
Cook Jennifer E.
Director · Common Stock · 2026-06-24
Exercise17.17K
Cook Jennifer E.
Director · Stock Option (Right to Buy) · 2026-06-24
Exercise20K
Cook Jennifer E.
Director · Common Stock · 2026-06-24
Sell37.17K
Valantine Hannah
Director · Common Stock · 2026-06-23
Sell2.2K
Cook Jennifer E.
Director · Common Stock · 2026-06-23
Sell2.2K
DANIELS RONALD J
Director · Common Stock · 2026-06-22
Grant3.99K
DANIELS RONALD J
Director · Stock Option (Right to Buy) · 2026-06-22
Grant5.28K
Dachille Douglas A.
Director · Common Stock · 2026-06-22
Grant3.99K

SEC filings

EDGAR filings in BBIO · 6 recent

EDGAR →

Get daily signals & real-time alerts.

StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 7 days, cancel in one click.

Start free — 7-day full access →

Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.